[Anticoagulants. 43].
D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology / Q000627:therapeutic use; D001728:Dicumarol / Q000627:therapeutic use; D006493:Heparin / Q000494:pharmacology / Q000627:therapeutic use; D006496:Heparinoids / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007982:Levulinic Acids / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D009354:Neodymium / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010630:Phenindione / Q000494:pharmacology / Q000627:therapeutic use; D011221:Praseodymium / Q000627:therapeutic use; D014652:Vascular Diseases / Q000188:drug therapy*
D000925:Anticoagulants; D003374:Coumarins; D006496:Heparinoids; D007982:Levulinic Acids; D009539:Nicotinic Acids; D009354:Neodymium; D010630:Phenindione; D001728:Dicumarol; D006493:Heparin; D008274:Magnesium; D011221:Praseodymium
Antikoagulanzien. 43.